FBXO7-mediated degradation of PRMT1 prevents PHGDH methylation and activation, thereby inhibiting serine synthesis, aggravating oxidative stress, and suppressing HCC growth in vitro and in vivo (Fig. 7m). This evidence concerns the gene FBXO7 and hepatocellular carcinoma.